310. Melatonin MT2 receptors activation attenuates MK-801-induced schizophrenia-like effects
Abstract Background Schizophrenia (SCZ) is a chronic psychiatric disorder characterized by positive, negative, and cognitive symptoms that remain insufficiently addressed by existing dopamine- and serotonin-based antipsychotics. Emerging evidence implicates melatonin MT2 receptors in the regulation of circadian rhythms...